1800 244 735

Start here!

Welcome to HDBuzz! This special page is for people who are new to Huntington’s disease, or new to the world of HD research.

Reading the articles linked here will help you pick up the basics of what Huntington’s disease is, and get up to speed with some of the most promising things scientists are doing to come up with effective treatments for HD.

Huntington’s disease – the bare essentials

    n

  • Our Science FAQ covers the very basics of HD and introduces some ideas about why we need research to find treatments.
  • n

About HDBuzz

    n

  • Our HDBuzz FAQ and People Page explain what HDBuzz is, and the people behind it.
  • n

  • And our Funding page explains where we get our money from and how we make sure HDBuzz is neutral and reliable.
  • n

The most promising possible treatments

Some of the world’s top scientists are working round the clock to develop treatments for Huntington’s disease – and real progress is being made. Dozens of possible treatments are being worked on, and every day a successful treatment gets one day closer. Here are some leading approaches being tested in the clinic.

Huntingtin lowering Huntington’s disease is caused by a faulty protein, and huntingtin lowering drugs tell cells to make less of that protein. Huntingtin lowering is sometimes called “gene silencing”. Right now many scientists believe it is our best hope for an effective treatment. Read about it in our Gene Silencing Primer.

Other approaches to addressing HD biology and HD symptoms include preserving the connections between nerve cells, enhancing certain types of signals in the brain, stopping CAG repeats from lengthening, and treating problems with thinking and movement. Read more about these approaches here.

Living with HD

Some of our most popular articles offer the latest information about day-to-day issues faced by Huntington’s disease family members.

    n

  • ‘Making Babies’ explains how people at risk of HD can use assisted fertility methods to have HD-free kids – even if the would-be parents don’t want to be tested themselves.
  • n

  • Our article on the ‘Genetic Gray Area’ of HD sheds light on the often confusing topic of people whose HD genetic test result isn’t quite positive or negative, but somewhere in the middle.
  • n

  • Many HD-affected people are frustrated by a lack of interest or expertise from care professionals. Take a look at our article on Closing the Care Gap to find out about the expert guidance available to professionals – why not show it to the professionals looking after you?
  • n

Taking action

Successful treatments to prevent, slow, reverse or cure Huntington’s disease will arrive more quickly if more people help out. Here’s what we recommend:

    n

  • Sign up for Enroll-HD, the largest global study of HD family members. Anyone from an HD family can sign up and you don’t need to have had a genetic test to do so. A short annual assessment involving questionnaires, thinking tests and a blood sample is all it takes to help us understand HD and put you in pole position for clinical trials.
  • n

  • In the USA, look at the HDSA’s TrialFinder, which will tell you what drug trials and other research studies are going on near you.
  • n

  • In Canada, look at the HSC’s Clinical Trial Locations page.
  • n

  • In Europe, check out the EHA and the Euro-HD Network.
  • n

  • In Australia, check out the HDNA’s Map-HD Registry.
  • n

  • If you are affected by Juvenile HD, Check out HDYO’s JOIN-HD Registry.
  • n

  • Elsewhere, the International Huntington Association will help you get involved.
  • n

Getting behind the headlines

A key mission of HDBuzz is to help our readers sort out the hope from the hype. News and blog stories can sometimes give a false impression of how promising a particular treatment is, or how soon it could deliver for HD-affected people.

    n

  • Our Ten Golden Rules article suggests ten simple steps to help you draw hope from a science news story, without being disappointed by impossible promises.
  • n

Meanwhile, there are many areas of science being explored as part of the larger “HD research pipeline” which are not yet ready to pursue in humans. Sometimes these are interesting and potentially useful, but sometimes they generate headlines that aren’t necessarily able to live up to the hype. Here are some examples of recent articles about broad topics, “basic science,” and techniques that are moving HD research forward.

The very latest

We regularly produce reports from major scientific meetings and conferences. They’re a great way to get an overview of all the hottest Huntington’s disease research. Catch up on the latest conference news here.

Make yourself at home!

HDBuzz is designed so that each article makes sense on its own and gives you all the background info you need. So don’t be afraid to explore.

    n

  • Each article has a learn more box, containing links to original sources and background information.
  • n

  • Every article has a topics box so you can easily find content on a particular subject.
  • n

If there’s something about HD research you’d like explained but can’t find here, feel free to use the ‘Suggest an article’ box on the front page.

And to make sure you don’t miss anything exciting, follow us on Twitter or Facebook, or sign up for Email updates

Welcome aboard. We’re glad you found us.

Latest Research Articles

Mini brains grown in a dish shed light on Huntington’s disease and how we might treat it

Published date: 23 August, 2024

Stem cells grown in 3D in a research lab can mimic some features of Huntington’s disease (HD). They also hold promise for transplantation studies to potentially add back cells that are lost in HD. But what would happen to those new cells? Would they get along with the cells still in the brain that have ... Read more

Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial

Published date: 16 August, 2024

New data from uniQure, who developed a one-and-done gene therapy for Huntington’s disease (HD) called AMT-130, indicates that the drug is relatively safe and might be able to slow down signs and symptoms of HD. AMT-130 is currently under investigation in Phase I/II clinical trials in Europe and the US which are mainly focused on ... Read more

Steady progress from uniQure – promising data to end the year

Published date: 16 August, 2024

With the holidays approaching, welcome news arrived on December 19th in a press release from uniQure. The latest data from the HD-GeneTRX studies of AMT-130, an experimental huntingtin-lowering gene therapy, shows that the drug still appears to be safe over the course of a few years. Since the number of participants is very small, we ... Read more

Hereditary Disease Foundation (HDF) conference 2024 – Day 4

Published date: 13 August, 2024

We’re back for the last day of the Hereditary Disease Foundation conference! Serendipitous finding? Up first is HDBuzz co-founder and editor emeritus, Jeff Carroll. Jeff’s lab studies HD in mice and cells in a dish and investigates different potential treatments. The first story Jeff is telling us about is developing tools that lower HTT. He’s ... Read more

Hereditary Disease Foundation (HDF) conference 2024 – Day 3

Published date: 12 August, 2024

We’re back for Day 3 of the Hereditary Disease Foundation (HDF) conference! First up is a session on RNA dynamics – what’s that?! Read on to find out! Different HTT forms have different effects Up first is Gill Bates, who will tell us about her work in understanding how somatic expansion causes disease and investigating ... Read more

Hereditary Disease Foundation (HDF) conference 2024 – Day 2

Published date: 10 August, 2024

Welcome to Day 2 of the Hereditary Disease Foundation (HDF) conference! The morning was spent listening to an interview between a neurologist and their patient living with HD. All HDF meetings begin this way, to better connect scientists with the people who matter most, those living with HD. Different flavors of HTT Up first is ... Read more